AI-assisted, human-published
05/01/2025 /Funding Events
CND Life Sciences Raises $13.5M in Series A3 Financing to Advance Neurodiagnostics Innovations
CND Life Sciences secures significant funding from Labcorp and other investors to further develop neurodiagnostics innovations, including AI-assisted platforms, for early and precise diagnosis of synuclein-associated disorders.
AI-assisted, human-published
Latest headlines
-
-
-
Stay connected!
If you have a serious, bonafide inquiry into the VentureCapital.com or PrivateEquity.com domain names, please contact us here
©2023 VentureCapital.com